Help make MDMA an approved medicine for PTSD. Historically, post-traumatic stress disorder (PTSD) has been notoriously difficult to treat and cure, but MDMA-assisted psychotherapy holds incredible promise. In trials with 107 participants, 56% no longer qualified for PTSD. At the 12-month follow-up, 67% no longer had PTSD. Most subjects received just 2–3 sessions. All participants had chronic, treatment-resistant PTSD and had suffered from PTSD for an average of 17.8 years.

This is addressing the root causes of PTSD and not simply masking symptoms, as many maintenance drugs do. It’s actual processing instead of numbing.

On August 16, 2017, the FDA granted Breakthrough Therapy Designation to MDMA for the treatment of PTSD, and there is a clear path for making MDMA a legal medicine for millions of people who are suffering.

This is the final stretch. MAPS has until September 10 to raise $10 million in order to unlock a $10 million challenge pledge. This, combined with $10 million already committed, will complete the $30 million Capstone Campaign. This will provide the funds needed to complete the studies required for FDA approval, and bring this much-needed treatment to patients.

Learn more by listening to the 6/12 episode of The Tim Ferriss Show, which features an interview with MAPS Founder and Executive Director, Rick Doblin, Ph.D: https://tim.blog/2020/06/11/rick-doblin/

Every dollar matters, so if the spirit moves you, please consider giving what you can.